https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3ACardiology%2F92%2FenTranslations:Cardiology/92/en - Revision history2026-08-15T05:02:44ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Cardiology/92/en&diff=124245&oldid=prevFuzzyBot: Importing a new version from external source2024-03-04T03:50:27Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>* V-HeFT (1986) — use of vasodilators (hydralazine & isosorbide dinitrate) in heart failure<br />
* ISIS-2 (1988) — use of aspirin in myocardial infarction<br />
* CASE I (1991) — use of [[antiarrhythmic agent]]s after a heart attack increases mortality<br />
* SOLVD (1991) — use of [[ACE inhibitor]]s in heart failure<br />
* 4S (1994) — [[statin]]s reduce risk of heart disease<br />
* CURE (1991) — use of [[dual antiplatelet therapy]] in [[NSTEMI]]<br />
* MIRACLE (2002) — use of [[cardiac resynchronization therapy]] in heart failure<br />
* SCD-HeFT (2005) — the use of [[implantable cardioverter-defibrillator]] in heart failure<br />
* RELY (2009), ROCKET-AF (2011), ARISTOTLE (2011) — use of [[DOAC]]s in [[atrial fibrillation]] instead of warfarin<br />
* PARADIGM-HF (2014) — use of angiotensin-neprilysin inhibitor in heart failure<br />
* ISCHEMIA (2020) — medical therapy is as good as [[coronary stent]]s in stable heart disease<br />
* EMPEROR-Preserved (2021) — SGLT2 receptors in heart failure</div>FuzzyBot